mannitol has been researched along with guaifenesin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.79) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Icard, BL; Rubio, E | 1 |
| Gooday, GW; Holligan, PM | 1 |
| Ahmed, IH; Hulbert, WC; Logus, JW; Man, GC; Man, SF; Mok, K; Yamamoto, H | 1 |
| Bayless, TM; Halsted, CH; Hendrix, TR; Luebbers, EH; Yardley, JH | 1 |
| Böttcher, W; Golanska, E; Kauffman, GL; Robert, A | 1 |
| Anderson, SD; Baker, J; Bye, PT; Chan, HK; Daviskas, E; Eberl, S; Robinson, M | 1 |
| Forbes, B; Hashmi, N; Lansley, AB; Martin, GP | 1 |
| Hirsh, AJ | 1 |
| Kim, JS; Kishioka, C; Okamoto, K; Rubin, BK | 1 |
| Abraham, WM; Boucher, RC; Hirsh, AJ; Hopkins, S; Paradiso, AM; Sabater, JR; Smith, RT; Zamurs, A | 1 |
| Anderson, SD; Daviskas, E | 1 |
| Brayden, DJ; Feighery, L; Maher, S; McClean, S | 1 |
| Anderson, SD; Daviskas, E; Young, IH | 1 |
| Anderson, SD; Daviskas, E; Eberl, S; Young, IH | 2 |
| Anderson, SD; Charlton, B; Daviskas, E; Jaques, A | 1 |
| Donaldson, SH; Paré, PD; Rosenfeld, M; Tiddens, HA | 1 |
| Lin, Q; Shin, S; Tsifansky, MD; Yang, Y; Yeo, Y | 1 |
| Daviskas, E; Rubin, BK | 1 |
| Ballerin, G; Buddle, L; Morgan, L; Ong, HX; Scalia, S; Traini, D; Young, PM | 1 |
| Rogers, DF; Tildy, BE | 1 |
| Gan, Y; Li, F; Li, J; Wu, N; Zhang, T; Zhang, X | 1 |
| Bennett, WD; Donaldson, SH; Henderson, AG | 1 |
| Cavallaro, G; Craparo, EF; Cusimano, MG; Giammona, G; Porsio, B; Schillaci, D; Spigolon, D | 1 |
| Jacobsen, J; Marxen, E; Mosgaard, MD; Pedersen, AML | 1 |
| Birch, D; Christophersen, PC; Diedrichsen, RG; Mu, H; Nielsen, HM | 1 |
| Abisheganaden, JA; Chandrasekaran, R; Chotirmall, SH; Hadinoto, K; Koh, MS; Lim, AYH; Low, TB; Roizman, D; Tan, GL; Teo, J; Tran, TT; Vidaillac, C; Yong, VFL; Yu, H | 1 |
| G, BR; Ganguli, M; Gupta, N; Kumari, A; Miglani, C; Mohny, FP; Pal, A; Pal, S; Pattnaik, B | 1 |
9 review(s) available for mannitol and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
Topics: Acetylcysteine; Ambroxol; Critical Care; Critical Illness; Deoxyribonuclease I; Expectorants; Guaifenesin; Humans; Intensive Care Units; Mannitol; Mucociliary Clearance; Potassium Dichromate; Recombinant Proteins; Respiration, Artificial; Saline Solution, Hypertonic; Sodium Bicarbonate | 2017 |
Symbiosis in Convoluta roscoffenis.
Topics: Alanine; Amino Acids; Animals; Carbon Dioxide; Chlorophyta; Ecology; Fatty Acids; Food; Lactates; Light; Mannitol; Mucus; Nitrates; Nitrogen; Photosynthesis; Starch; Symbiosis; Turbellaria; Uric Acid | 1975 |
Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents.
Topics: Administration, Inhalation; Amiloride; Cystic Fibrosis; Epithelium; Humans; Mannitol; Mucociliary Clearance; Mucus; Osmotic Pressure; Respiratory System; Saline Solution, Hypertonic; Sodium Channel Blockers | 2002 |
Hyperosmolar agents and clearance of mucus in the diseased airway.
Topics: Aerosols; Humans; Mannitol; Mucociliary Clearance; Mucus; Quality of Life; Respiratory Tract Diseases; Saline Solution, Hypertonic | 2006 |
Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
Topics: Administration, Inhalation; Airway Obstruction; Airway Remodeling; Anti-Inflammatory Agents; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Deoxycytosine Nucleotides; Humans; Infant; Ion Transport; Mannitol; Mucociliary Clearance; Mucus; Neutrophils; Pneumonia, Bacterial; Pulmonary Alveoli; Radiography; Respiratory Mucosa; Sodium Channel Blockers; Uridine; Young Adult | 2010 |
Effect of inhaled dry powder mannitol on mucus and its clearance.
Topics: Administration, Inhalation; Bronchiectasis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Mannitol; Mucociliary Clearance; Mucus; Powders; Treatment Outcome | 2013 |
Therapeutic options for hydrating airway mucus in cystic fibrosis.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mannitol; Mucus; Respiratory System; Saline Solution, Hypertonic | 2015 |
Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis.
Topics: Administration, Inhalation; Bronchitis, Chronic; Cystic Fibrosis; Diuretics, Osmotic; Epithelial Sodium Channel Blockers; Humans; Mannitol; Mucociliary Clearance; Mucus; Saline Solution, Hypertonic | 2016 |
4 trial(s) available for mannitol and guaifenesin
| Article | Year |
|---|---|
The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
Topics: Administration, Inhalation; Adolescent; Adult; Bronchi; Cough; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Mucus; Pilot Projects; Saline Solution, Hypertonic; Treatment Outcome | 1999 |
Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis.
Topics: Administration, Inhalation; Aged; Bronchiectasis; Cough; Diuretics, Osmotic; Dose-Response Relationship, Drug; Female; Humans; Male; Mannitol; Middle Aged; Mucus | 2008 |
Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
Topics: Administration, Inhalation; Adult; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Elasticity; Forced Expiratory Volume; Humans; Lung; Mannitol; Mucus; Sputum; Vital Capacity | 2010 |
Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
Topics: Administration, Inhalation; Adult; Aged; Bronchiectasis; Cough; Dose-Response Relationship, Drug; Female; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Mucus; Powders; Spirometry; Treatment Outcome | 2010 |
16 other study(ies) available for mannitol and guaifenesin
| Article | Year |
|---|---|
Effects of irradiation on canine tracheal epithelium: a physiological and morphological correlate.
Topics: Animals; Biological Transport; Dogs; Electrophysiology; Epithelium; Mannitol; Microscopy, Electron, Scanning; Mucus; Permeability; Trachea | 1987 |
Goblet cell mucus in the small intestine. Findings after net fluid production due to cholera toxin and hypertonic solutions.
Topics: Animals; Cholera; Cycloheximide; Glucose; Hypertonic Solutions; Ileum; Intestinal Mucosa; Intestine, Small; Jejunum; Mannitol; Mucus; Rabbits; Toxins, Biological | 1972 |
Lack of correlation between mucus gel thickness and gastric cytoprotection in rats.
Topics: Animals; Dinoprostone; Ethanol; Evaluation Studies as Topic; Gastric Mucosa; Glucose; Hydrochloric Acid; Male; Mannitol; Mucus; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Saline Solution, Hypertonic; Sodium Chloride; Sodium Salicylate; Time Factors | 1984 |
Formulation of inhaled medicines: effect of delivery vehicle on immortalized epithelial cells.
Topics: Analysis of Variance; Bronchi; Cells, Cultured; Colon; Epithelial Cells; Excipients; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Mannitol; Mucus; Osmolar Concentration; Permeability | 2000 |
Hyperosmolar solutions stimulate mucus secretion in the ferret trachea.
Topics: Animals; Female; Ferrets; Glucose; Hypertonic Solutions; Male; Mannitol; Mucins; Mucus; Muramidase; Saline Solution, Hypertonic; Stimulation, Chemical; Trachea; Tromethamine | 2003 |
Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
Topics: Absorption; Amiloride; Animals; Bronchi; Cystic Fibrosis; Electrophysiology; Epithelial Cells; Epithelial Sodium Channels; Epithelium; Female; Humans; In Vitro Techniques; Lung Diseases; Mannitol; Microscopy, Confocal; Mucus; Muscle Contraction; Sheep; Sodium; Sodium Channel Blockers; Sodium Channels; Viscosity | 2004 |
Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Topics: Animals; Caco-2 Cells; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cell Survival; Colon; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Drug Stability; Electric Impedance; Hemolysis; HT29 Cells; Humans; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Mannitol; Melitten; Membrane Potentials; Mucus; Permeability; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Tritium | 2007 |
Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion.
Topics: Aged; Asthma; Bronchodilator Agents; Diuretics, Osmotic; Elasticity; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Mannitol; Middle Aged; Mucus; Rheology; Sputum; Surface Properties; Viscosity | 2007 |
Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.
Topics: Administration, Inhalation; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Drug Carriers; Humans; Mannitol; Mucus; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Chloride | 2011 |
Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Cells, Cultured; Cilia; Drug Therapy, Combination; Humans; Lung Diseases; Mannitol; Microscopy, Electron, Scanning; Mucus; Muscle, Smooth | 2014 |
Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
Topics: Administration, Intravaginal; Animals; Drug Carriers; Drug Delivery Systems; Female; Humans; Hypromellose Derivatives; Mannitol; Mucus; Nanoparticles; Particle Size; Poloxamer; Powders; Rabbits; Rats; Rats, Inbred Lew; Rheology; RNA, Small Interfering; Ultrasonics; Vagina | 2015 |
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Drug Carriers; Drug Liberation; Epithelial Cells; Humans; Mannitol; Mucus; Nanocomposites; Polyelectrolytes; Polymers; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2017 |
Mucin dispersions as a model for the oromucosal mucus layer in in vitro and ex vivo buccal permeability studies of small molecules.
Topics: Caffeine; Cell Line; Diffusion; Epithelium; Gastric Mucins; Humans; Mannitol; Mouth Mucosa; Mucus; Nicotine; Permeability; Propranolol; Small Molecule Libraries | 2017 |
Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Topics: Caco-2 Cells; Cell Survival; Coculture Techniques; Cyclosporine; Deamino Arginine Vasopressin; Fenofibrate; HT29 Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mannitol; Metoprolol; Models, Biological; Mucus; Ovalbumin; Permeability | 2018 |
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Case-Control Studies; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Humans; Lactose; Lung; Mannitol; Mucus; Permeability; Pseudomonas aeruginosa | 2018 |
Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.
Topics: Cell-Penetrating Peptides; Drug Carriers; Lung; Mannitol; Mucins; Mucus; Nanoparticles; Nucleic Acids | 2022 |